Neurocrine Bioscience buy Cantor Fitzgerald
Start price
25.07.24
/
50%
€136.10
Target price
25.07.25
€142.68
Performance (%)
-1.07%
Price
25.07.24
€134.65
Summary
This prediction is currently active. With a performance of -1.07%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 25.07.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Neurocrine Bioscience | -1.07% |
iShares Core DAX® | 0.039% |
iShares Nasdaq 100 | -4.018% |
iShares Nikkei 225® | -2.389% |
iShares S&P 500 | -2.115% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $155.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.55
10.04.24
10.04.24
€144.01
10.04.25
10.04.25
3.94%
25.07.24
25.07.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€102.55
24.10.23
24.10.23
-
24.10.24
24.10.24
29.99%
25.07.24
25.07.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€126.70
13.09.24
13.09.24
25.55%
25.07.24
25.07.24